China Life Insurance (601628.SH) plans to contribute no more than 4.5 billion yuan to jointly establish a partnership with related parties and others.

China Life Insurance (601628.SH) announced that the company, Wuxi Guoshou Chengda Equity Investment Center (Limited Partnership) ("Guoshou Wuxi Fund"), and other investors (each party acting as a limited partner) intend to enter into a partnership agreement with Guoshou Chengda (Shanghai) Healthcare Equity Investment Management Co., Ltd. ("Guoshou Chengda") (acting as the general partner) to establish Qingdao Chengxin Zhida Equity Investment Center (Limited Partnership). The total subscribed capital contribution of all partners of the partnership is intended to be no more than 6 billion yuan, of which the company intends to subscribe no more than 4.5 billion yuan. The partnership will closely align with the policy direction of technological self-reliance and self-strengthening and industrial autonomy and controllability, focusing on investment in the two major technological innovation sectors of artificial intelligence and semiconductors, and concentrating on equity in high-quality unlisted enterprises that possess core technological barriers in the industrial chain, have broad space for domestic substitution, and demonstrate outstanding long-term growth certainty.